APA

Bregvadze I. N., Maĭkov E. B., Bil'dinov O. A., Kratskina T. L., Klimenko I. L., Smirnova M. I., Sokolov S. F., Golitsyn S. P., Rozenshtraukh L. V. & Chazov E. I. (20070709). [The efficacy and safety of nibentan for pharmacological cardioversion in patients with persistent atrial fibrillation and flutter: the role of dose limitation and magnesium sulfate administration]. : Kardiologiia.

Chicago

Bregvadze I N, Maĭkov E B, Bil'dinov O A, Kratskina T L, Klimenko Iu L, Smirnova M Iu, Sokolov S F, Golitsyn S P, Rozenshtraukh L V and Chazov E I. 20070709. [The efficacy and safety of nibentan for pharmacological cardioversion in patients with persistent atrial fibrillation and flutter: the role of dose limitation and magnesium sulfate administration]. : Kardiologiia.

Harvard

Bregvadze I. N., Maĭkov E. B., Bil'dinov O. A., Kratskina T. L., Klimenko I. L., Smirnova M. I., Sokolov S. F., Golitsyn S. P., Rozenshtraukh L. V. and Chazov E. I. (20070709). [The efficacy and safety of nibentan for pharmacological cardioversion in patients with persistent atrial fibrillation and flutter: the role of dose limitation and magnesium sulfate administration]. : Kardiologiia.

MLA

Bregvadze I N, Maĭkov E B, Bil'dinov O A, Kratskina T L, Klimenko Iu L, Smirnova M Iu, Sokolov S F, Golitsyn S P, Rozenshtraukh L V and Chazov E I. [The efficacy and safety of nibentan for pharmacological cardioversion in patients with persistent atrial fibrillation and flutter: the role of dose limitation and magnesium sulfate administration]. : Kardiologiia. 20070709.